share_log

Ian Sacks Sells 25,000 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

Ian Sacks Sells 25,000 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

伊恩·萨克斯出售25,000股医疗股权公司(纳斯达克代码:HQY)股票
kopsource ·  2022/09/22 17:32

HealthEquity, Inc. (NASDAQ:HQY – Get Rating) Director Ian Sacks sold 25,000 shares of the company's stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $72.28, for a total transaction of $1,807,000.00. Following the completion of the transaction, the director now directly owns 126,570 shares of the company's stock, valued at $9,148,479.60. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

纳斯达克股票代码:HQY-GET评级)董事伊恩·萨克斯在一笔日期为9月20日(星期二)的交易中出售了25,000股该公司股票。这些股票的平均价格为72.28美元,总成交金额为1,807,000.00美元。交易完成后,董事现在直接持有该公司126,570股股票,价值9,148,479.60美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过此超链接.

HealthEquity Price Performance

HealthEquity价格表现

Shares of HealthEquity stock traded up $1.65 on Thursday, hitting $73.50. The company had a trading volume of 1,162,452 shares, compared to its average volume of 749,338. The business has a 50-day simple moving average of $62.70 and a 200-day simple moving average of $62.64. The company has a market cap of $6.21 billion, a PE ratio of -99.27, a PEG ratio of 4.25 and a beta of 0.90. HealthEquity, Inc. has a 52 week low of $36.81 and a 52 week high of $74.04.

HealthEquity股价周四上涨1.65美元,至73.50美元。该公司的成交量为1,162,452股,而其平均成交量为749,338股。该业务的50日简单移动均线切入位在62.70美元,200日简单移动均线切入位在62.64美元。该公司市值为62.1亿美元,市盈率为-99.27,聚乙二醇率为4.25,贝塔系数为0.90。HealthEquity,Inc.的52周低点为36.81美元,52周高位为74.04美元。

Get
到达
HealthEquity
健康权益
alerts:
警报:

HealthEquity (NASDAQ:HQY – Get Rating) last issued its earnings results on Tuesday, September 6th. The company reported $0.33 earnings per share for the quarter, hitting analysts' consensus estimates of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same quarter in the previous year, the business earned $0.21 earnings per share. On average, equities research analysts predict that HealthEquity, Inc. will post 0.69 earnings per share for the current fiscal year.

健康股权(纳斯达克代码:HQY-GET Rating)最近一次发布财报是在9月6日(星期二)。该公司公布本季度每股收益为0.33美元,超过了分析师普遍预期的0.33美元。HealthEquity的净利润率为负7.82%,股本回报率为正2.86%。去年同一季度,该业务每股收益为0.21美元。股票研究分析师平均预测,HealthEquity,Inc.本财年每股收益将为0.69美元。

Analyst Upgrades and Downgrades

分析师升级和下调评级

HQY has been the subject of a number of analyst reports. KeyCorp initiated coverage on shares of HealthEquity in a research report on Thursday, September 15th. They issued an "overweight" rating and a $85.00 price objective for the company. Robert W. Baird upped their target price on shares of HealthEquity from $47.00 to $67.00 and gave the company a "neutral" rating in a research note on Wednesday, September 7th. SVB Leerink upped their target price on shares of HealthEquity from $67.00 to $76.00 and gave the company an "outperform" rating in a research note on Tuesday, June 7th. Wells Fargo & Company increased their price objective on shares of HealthEquity from $95.00 to $100.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 13th. Finally, The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research note on Tuesday, July 12th. They set a "sell" rating and a $59.00 price objective on the stock. Two analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $75.36.
HQY一直是多份分析师报告的主题。KeyCorp在9月15日星期四的一份研究报告中启动了对HealthEquity股票的报道。他们对该公司的评级为“增持”,目标价为85.00美元。9月7日,周三,罗伯特·W·贝尔德在一份研究报告中将HealthEquity的目标价从47.00美元上调至67.00美元,并给予该公司“中性”评级。6月7日,周二,SVB Leerink在一份研究报告中将HealthEquity的目标价从67.00美元上调至76.00美元,并给予该公司“跑赢大盘”的评级。富国银行将HealthEquity股票的目标价从95美元上调至100.00美元,并在9月13日(星期二)的一份研究报告中给予该股“增持”评级。最后,高盛在7月12日星期二的一份研究报告中对HealthEquity的股票进行了报道。他们为该股设定了“卖出”评级和59.00美元的目标价。两名分析师对该股的评级为卖出,一名分析师发布了持有评级,11名分析师对该股给予了买入评级。根据MarketBeat.com的数据,该股的共识评级为“适度买入”,共识目标价为75.36美元。

Institutional Investors Weigh In On HealthEquity

机构投资者参与HealthEquity

Several hedge funds have recently made changes to their positions in the company. Private Trust Co. NA purchased a new stake in HealthEquity in the 2nd quarter worth approximately $28,000. Assetmark Inc. lifted its position in HealthEquity by 387.1% in the 2nd quarter. Assetmark Inc. now owns 755 shares of the company's stock worth $46,000 after buying an additional 600 shares in the last quarter. Signaturefd LLC lifted its position in HealthEquity by 44.3% in the 1st quarter. Signaturefd LLC now owns 954 shares of the company's stock worth $64,000 after buying an additional 293 shares in the last quarter. Clearstead Advisors LLC bought a new position in shares of HealthEquity during the 1st quarter valued at $65,000. Finally, Eagle Bay Advisors LLC raised its holdings in shares of HealthEquity by 137.8% during the 2nd quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company's stock valued at $68,000 after purchasing an additional 642 shares in the last quarter. Hedge funds and other institutional investors own 99.43% of the company's stock.

几家对冲基金最近对他们在该公司的头寸进行了调整。私人信托公司NA在第二季度购买了HealthEquity的新股份,价值约28,000美元。AssetMark Inc.在第二季度将其在HealthEquity的持仓提高了387.1%。AssetMark Inc.目前持有该公司755股股票,价值46,000美元,此前该公司在上个季度又购买了600股。Signaturefd LLC在第一季度将其在HealthEquity的头寸提高了44.3%。Signaturefd LLC现在持有该公司954股股票,价值6.4万美元,上个季度又购买了293股。Clearstead Advisors LLC在第一季度购买了HealthEquity的新头寸,价值6.5万美元。最后,鹰湾顾问有限责任公司在第二季度增持了137.8%的HealthEquity股票。Eagle Bay Advisors LLC现在持有该公司1,108股股票,价值6.8万美元,此前该公司在上个季度又购买了642股。对冲基金和其他机构投资者持有该公司99.43%的股票。

HealthEquity Company Profile

HealthEquity公司简介

(Get Rating)

(获取评级)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

HealthEquity,Inc.为美国的消费者和雇主提供技术支持的服务平台。该公司提供基于云的平台,供个人做出健康储蓄和支出决定、支付医疗账单、比较治疗方案和价格、接收个性化福利和临床信息、赚取健康激励、增加储蓄并做出投资选择;以及健康储蓄账户。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on HealthEquity (HQY)
  • The Institutions Hold On To Darden Restaurants International
  • What Steelcase's Earnings Say About the Return to the Office?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Is The Golden Age Of Homebuilding Already Over?
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • 免费获取StockNews.com关于HealthEquity(HQY)的研究报告
  • 这些机构持有达顿餐饮国际公司的股份
  • 斯蒂尔凯斯的收益说明了他重返办公室的原因吗?
  • 这三大股利支付者也拥有强劲的价格增长
  • 住房建设的黄金时代已经结束了吗?
  • 天然气价格继续回升,这些股票应该会受益

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.

接受HealthEquity Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对HealthEquity和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发